IP Library › Assignment 059323/0175
Patent Assignment
Reel/Frame 059323/0175

Change of Name

Recorded: 2022-03-05 Pages: 2
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-12-02
Assignee
UCB BIOPHARMA SRL
ALLEE DE LA RECHERCHE, 60, BRUSSELS, B-1070, BELGIUM
Covered Properties (3)
2-Oxo-1-Pyrrolidine Derivatives
Patent: 8,183,241 →
Application: 11/916,231 →
Publication: US 2009/0156607
2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
Patent: 8,518,943 →
Application: 13/441,451 →
Publication: US 2012/0214815
Compounds for Enhancing the Cognitive Function
Patent: 9,630,948 →
Application: 14/909,246 →
Publication: US 2016/0185761
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 24, 2008
From: KENDA, BENOIT; QUESNEL, YANNICK; ATES, ALI; MICHEL, PHILIPPE
To: UCB PHARMA, S.A.
Reel/Frame 020409/0932 →
Assignment of Assignor's Interest Apr 9, 2012
From: KENDA, BENOIT; QUESNEL, YANNICK; ATES, ALI; MICHEL, PHILIPPE
To: UCB PHARMA, S.A.
Reel/Frame 028015/0033 →
Confirmatory Assignment Jun 10, 2016
From: UCB PHARMA, S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 038953/0312 →
Assignment of Assignor's Interest Feb 2, 2017
From: MONTEL, FLORIAN; JNOFF, ERIC
To: UCB PHARMA, S.A.
Reel/Frame 041155/0938 →
Assignment of Assignor's Interest Dec 11, 2017
From: UCB PHARMA S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 044349/0206 →
Corrective Assignment to Correct the Assignor Name in the Assignment Document Previously Recorded at Reel: 044349 Frame: 0206. Assignor(S) Hereby Confirms the Assignment. Mar 4, 2022
From: UCB PHARMA, S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 059320/0513 →